Interventional Cardiologist

Global Medical Director, Interventional Cardiology Work mode: Hybrid Onsite Location(s): Maple Grove, MN, US, 55311 Additional Location(s): US-MN-Maple Grove Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance At Boston Scientific, we'll give you the opportunity to harness all that's within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we'll help you in advancing your skills and career. Here, you'll be supported in progressing whatever your ambitions. About the role: Boston Scientific is seeking an experienced Interventional Cardiologist to join our Global Cardiology Group as a Global Medical Director. Boston Scientific was recognized as a Best Glassdoor Place to Work in 2026, ranking No. 15 on the Top 100 list, reflecting the culture our employees experience every day. In this physician leadership role, you will provide medical expertise and strategic guidance across the lifecycle of innovative cardiovascular therapies, including coronary, structural heart and renal denervation technologies. As the voice of the physician and patient, you will partner with Clinical, Research and Development (R&D), Quality, Regulatory Affairs and Commercial teams to support clinical evidence generation, product development, patient safety and medical strategy. This role offers a unique opportunity to influence the future of cardiovascular care by applying deep clinical expertise to advance safe, effective and clinically meaningful therapies for patients worldwide. Work model, and sponsorship: This role is hybrid at our Maple Grove, MN location, and being in the office for minimum three times a week. Boston Scientific will not offer sponsorship or take over sponsorship of an employment visa for this position at this time. Your responsibilities will include: Serve as the medical expert and patient advocate for cardiovascular therapies throughout the product lifecycle. Provide medical leadership and benefit-risk assessment across product development, clinical studies and post-market activities. Partner with Clinical, Clinical Evidence, Quality, Regulatory Affairs, R&D, Marketing and Business Development teams to support medical strategy and decision-making. Provide medical oversight for clinical studies, including protocol development, investigator engagement, patient safety monitoring, data interpretation and scientific dissemination. Support post-market surveillance, safety signal assessment, risk management activities and health hazard evaluations. Collaborate with health care providers, investigators and internal teams to evaluate adverse events, device performance trends and emerging clinical and safety concerns. Represent Boston Scientific with regulatory authorities, key opinion leaders, professional societies and advisory boards. Review and approve clinical, scientific, educational and regulatory materials to ensure medical accuracy and compliance. Contribute clinical expertise to innovation initiatives, portfolio strategy, business development evaluations, product development activities and due diligence efforts. Support training, mentorship and development of medical and cross-functional teams. Required qualifications: Valid and unrestricted Medical Doctor (MD) degree or accepted international equivalent. Board certified or board eligible in Interventional Cardiology, or equivalent international certification. Valid, unrestricted license to practice medicine and in good standing with the applicable licensing authority. Minimum of 5 years' experience in independent Interventional Cardiology practice, including management of complex coronary, structural heart and advanced interventional procedures. Demonstrated expertise in Interventional Cardiology and Structural Heart therapies, with strong clinical judgment and patient-centered decision-making. Strong ability to evaluate clinical and safety data, assess benefit-risk profiles and apply sound medical judgment to complex issues. Working knowledge of clinical trial methodology, Good Clinical Practice (GCP), medical device development. Preferred qualifications: Demonstrated interest and commitment to transitioning from clinical practice to the medical device industry, with realistic expectations about the learning curve and a willingness to contribute in a hands-on role while building industry experience. Proven experience as a clinical investigator, medical advisor or consultant within the medical device, biotechnology or pharmaceutical industry. Participation in Clinical Events Committees (CEC), Data Monitoring Committees (DMC), Institutional Review Boards (IRB) or similar scientific oversight bodies. Knowledge of medical risk management, post-market surveillance and global medical device regulations. Global perspective and familiarity with evolving interventional cardiology and structural heart practices across diverse health care systems. Requisition ID: 629847 Minimum Salary: $ 203000 Maximum Salary: $ 345100 The anticipated compensation listed above and the value of core and optional employee benefits offered by Boston Scientific (BSC) see will vary based on actual location of the position and other pertinent factors considered in determining actual compensation for the role. Compensation will be commensurate with demonstrable level of experience and training, pertinent education including licensure and certifications, among other relevant business or organizational needs. At BSC, it is not typical for an individual to be hired near the bottom or top of the anticipated salary range listed above. Compensation for non-exempt (hourly), non-sales roles may also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements). Compensation for exempt, non-sales roles may also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements). For MA positions: It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability. Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Boston Scientific Corporation has been and will continue to be an equal opportunity employer. To ensure full implementation of its equal employment policy, the Company will continue to take steps to assure that recruitment, hiring, assignment, promotion, compensation, and all other personnel decisions are made and administered without regard to race, religion, color, national origin, citizenship, sex, sexual orientation, gender identity, gender expression, veteran status, age, mental or physical disability, genetic information or any other protected class. Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company's policies or protocols change with regard to COVID-19 vaccination.